[The protective effect of intracerebroventricular administration of A-agonists in complete cerebral ischemia].
Kulinskiĭ
V I
VI
Usov
L A
LA
Sufianova
G Z
GZ
Sufianov
A A
AA
D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology*; D019830:Adenosine-5'-(N-ethylcarboxamide); D000818:Animals; D002545:Brain Ischemia / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D005260:Female; D007276:Injections, Intraventricular; D008297:Male; D051379:Mice; D018047:Receptors, Purinergic P1 / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*
D018047:Receptors, Purinergic P1; D014665:Vasodilator Agents; D019830:Adenosine-5'-(N-ethylcarboxamide); D000241:Adenosine
Zashchitnyĭ éffekt intratserebroventrikuliarnogo vvedeniia A-agonistov pri polnoĭ ishemii golovnogo mozga.